What changed in Revvity, Inc's latest annual report
In the year ended 28 Dec 2025, Revvity, Inc's revenue rose 3.7% to USD 2.86bn, from USD 2.76bn; net income fell 10.8% to USD 241.20m, from USD 270.38m; cash and cash equivalents fell 20.9% to USD 919.86m, from USD 1.16bn.
Year ended 28 Dec 2025. Source: 10-K filed 24 Feb 2026, read it on SEC EDGAR.
USD 2.76bn to USD 2.86bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 2.76bn | 2.86bn | Up 3.7% |
| Net income | 270.38m | 241.20m | Down 10.8% |
| Total assets | 12.39bn | 12.17bn | Down 1.8% |
| Total liabilities | 4.73bn | 4.92bn | Up 4.1% |
| Long-term debt | 3.15bn | 2.63bn | Down 16.5% |
| Cash and cash equivalents | 1.16bn | 919.86m | Down 20.9% |
| Shareholders' equity | 7.67bn | 7.25bn | Down 5.4% |
Questions people ask
Did Revvity, Inc's revenue grow last year?
Revenue grew 3.7%, from USD 2.76bn to USD 2.86bn in the year ended 28 Dec 2025.
Is Revvity, Inc profitable?
Yes. Net income was USD 241.20m in the year ended 28 Dec 2025. The year before: USD 270.38m.
How much cash and debt does Revvity, Inc have?
At its latest year end (28 Dec 2025), Revvity, Inc reported cash and cash equivalents of USD 919.86m and long-term debt of USD 2.63bn.
Where do these numbers come from?
From Revvity, Inc's own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Revvity, Inc?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Laboratory Analytical Instruments companies
- Agilent Technologies, Inc.Cash and cash equivalents up 34.6%
- Waters CorporationCash and cash equivalents up 80.7%
- Illumina, Inc.Shareholders' equity up 14.7%
- Mettler-Toledo International Inc.Total assets up 14.6%
- Avantor, Inc.Cash and cash equivalents up 39.5%
- 10x Genomics, Inc.Total liabilities up 17.5%
- Bio-Rad Laboratories, Inc.Shareholders' equity up 13.5%